Positions

Selected Publications

Academic Article

Year Title Altmetric
2018 Correlation between Dt/V derived from ionic dialysance and blood-driven Kt/V of urea in African-American hemodialysis patients, based on body weight and ultrafiltration volume.Clinical Kidney Journal.  11:734-741. 2018
2018 Overview of Current and Future Adjuvant Therapy for High-Risk Localized Renal Cell Carcinoma.Current Treatment Options in Oncology.  19:2. 2018
2017 Timing of androgen-deprivation therapy in prostate cancer.Lancet Oncology.  18:e634. 2017
2017 Treatment approaches of hard-to-treat non-Hodgkin lymphomas.Expert Review of Hematology.  10:259-273. 2017
2016 Circulating Biomarkers in Bladder Cancer.Bladder cancer.  2:369-379. 2016
2016 Bronchoscopy can be done safely in patients with thrombocytopenia.Transfusion.  56:344-348. 2016
2014 Ectopic ACTH and cisplatin toxicity--a diagnostic dilemma.American Journal of Therapeutics.  21:e154-e156. 2014
2013 A rare cause of dysphagia in a HIV patient--esophageal pseudodiverticulosis.Acta Gastroenterologica Belgica.  76:340-341. 2013
2013 Sterile peritonitis because of splenic infarction in a patient on peritoneal dialysis: an unusual presentation.Peritoneal Dialysis International.  33:339-340. 2013

Research Overview

  • Dr. Nandagopal’s primary clinic interest is interested in genitourinary (GU) malignancies. His research interests are in developing clinical trials for GU malignancies, and development of correlative and prognostic biomarkers.
  • Investigator On

  • Private Grant  awarded by ASTRAZENECA AB 2018 - 2023
  • Private Grant  awarded by CLOVIS ONCOLOGY 2017 - 2022
  • Private Grant  awarded by CLOVIS ONCOLOGY 2017 - 2022
  • Education And Training

  • Bachelor of Medicine & Surgery (MBBS), Tamil Nadu Doctor M.G.R. Medical University
  • Full Name

  • Lakshminarayanan Nandagopal
  • Blazerid

  • lnandago